| Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity D Shin, R Mukherjee, D Grewe, D Bojkova, K Baek, A Bhattacharya, ... Nature 587 (7835), 657-662, 2020 | 926 | 2020 |
| Proteomics of SARS-CoV-2-infected host cells reveals therapy targets D Bojkova, K Klann, B Koch, M Widera, D Krause, S Ciesek, J Cinatl, ... Nature 583 (7816), 469-472, 2020 | 904 | 2020 |
| Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China S Hoehl, H Rabenau, A Berger, M Kortenbusch, J Cinatl, D Bojkova, ... New England Journal of Medicine 382 (13), 1278-1280, 2020 | 761 | 2020 |
| SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes D Bojkova, JUG Wagner, M Shumliakivska, GS Aslan, U Saleem, ... Cardiovascular research 116 (14), 2207-2215, 2020 | 234 | 2020 |
| The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells J Wenzel, J Lampe, H Müller-Fielitz, R Schuster, M Zille, K Müller, ... Nature neuroscience 24 (11), 1522-1533, 2021 | 211 | 2021 |
| Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication K Klann, D Bojkova, G Tascher, S Ciesek, C Münch, J Cinatl Molecular cell 80 (1), 164-174. e4, 2020 | 208 | 2020 |
| Lack of antiviral activity of darunavir against SARS-CoV-2 S De Meyer, D Bojkova, J Cinatl, E Van Damme, C Buyck, M Van Loock, ... International Journal of Infectious Diseases 97, 7-10, 2020 | 150 | 2020 |
| Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates D Bojkova, M Widera, S Ciesek, MN Wass, M Michaelis, J Cinatl Jr Cell research 32 (3), 319-321, 2022 | 121 | 2022 |
| Optimized qRT-PCR approach for the detection of intra-and extra-cellular SARS-CoV-2 RNAs T Toptan, S Hoehl, S Westhaus, D Bojkova, A Berger, B Rotter, ... International journal of molecular sciences 21 (12), 4396, 2020 | 85 | 2020 |
| Aprotinin inhibits SARS-CoV-2 replication D Bojkova, M Bechtel, KM McLaughlin, JE McGreig, K Klann, ... Cells 9 (11), 2377, 2020 | 82 | 2020 |
| SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles D Bojkova, JE McGreig, KM McLaughlin, SG Masterson, M Widera, ... BioRxiv, 2020.04. 03.024257, 2020 | 72 | 2020 |
| Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection B Ellinger, D Bojkova, A Zaliani, J Cinatl, C Claussen, S Westhaus, ... | 68 | 2020 |
| Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies LA Armstrong, SM Lange, V Dee Cesare, SP Matthews, RS Nirujogi, ... PloS one 16 (7), e0253364, 2021 | 66 | 2021 |
| A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection B Ellinger, D Bojkova, A Zaliani, J Cinatl, C Claussen, S Westhaus, ... Scientific data 8 (1), 70, 2021 | 63 | 2021 |
| Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection R Mukherjee, A Bhattacharya, D Bojkova, AR Mehdipour, D Shin, ... Journal of Biological Chemistry 297 (2), 2021 | 53 | 2021 |
| SARS-CoV-2 infected host cell proteomics reveal potential therapy targets D Bojkova, K Klann, B Koch, M Widera, D Krause, S Ciesek, J Cinatl, ... | 49 | 2020 |
| Metallodrug Profiling against SARS‐CoV‐2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain‐like Protease PLpro M Gil‐Moles, S Türck, U Basu, A Pettenuzzo, S Bhattacharya, A Rajan, ... Chemistry–A European Journal 27 (71), 17928-17940, 2021 | 45 | 2021 |
| Infectivity of deceased COVID-19 patients S Plenzig, D Bojkova, H Held, A Berger, F Holz, J Cinatl, E Gradhand, ... International journal of legal medicine 135, 2055-2060, 2021 | 43 | 2021 |
| Targeting the pentose phosphate pathway for SARS-CoV-2 therapy D Bojkova, R Costa, P Reus, M Bechtel, MC Jaboreck, R Olmer, U Martin, ... Metabolites 11 (10), 699, 2021 | 40 | 2021 |
| Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings M Widera, S Westhaus, HF Rabenau, S Hoehl, D Bojkova, J Cinatl Jr, ... Medical microbiology and immunology 210 (4), 235-244, 2021 | 40 | 2021 |
